These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26666878)

  • 1. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
    Kocova M; Kochova E; Sukarova-Angelovska E
    BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
    Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
    Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
    Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M
    Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare case of optic pathway glioma with extensive intra-ocular involvement in a child with neurofibromatosis type 1.
    Gupta V; Sabri K; Whelan KF; Viscardi V
    Middle East Afr J Ophthalmol; 2015; 22(1):117-8. PubMed ID: 25624686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.
    Pinheiro SL; Maciel J; Cavaco D; Figueiredo AA; Damásio IL; Donato S; Passos J; Simões-Pereira J
    Hormones (Athens); 2023 Mar; 22(1):79-85. PubMed ID: 36269545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.
    Peces R; Mena R; Martín Y; Hernández C; Peces C; Tellería D; Cuesta E; Selgas R; Lapunzina P; Nevado J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1321. PubMed ID: 32533764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.
    Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
    Cnossen MH; Stam EN; Cooiman LC; Simonsz HJ; Stroink H; Oranje AP; Halley DJ; de Goede-Bolder A; Niermeijer MF; de Muinck Keizer-Schrama SM
    Pediatrics; 1997 Oct; 100(4):667-70. PubMed ID: 9310522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precocious puberty in two children with neurofibromatosis type I in the absence of optic chiasmal glioma.
    Zacharin M
    J Pediatr; 1997 Jan; 130(1):155-7. PubMed ID: 9003867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
    Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
    Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations.
    Sharif S; Upadhyaya M; Ferner R; Majounie E; Shenton A; Baser M; Thakker N; Evans DG
    J Med Genet; 2011 Apr; 48(4):256-60. PubMed ID: 21278392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gigantism due to growth hormone excess in a boy with optic glioma.
    Drimmie FM; MacLennan AC; Nicoll JA; Simpson E; McNeill E; Donaldson MD
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):535-8. PubMed ID: 11012581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and pubertal disorders in neurofibromatosis type 1.
    Virdis R; Street ME; Bandello MA; Tripodi C; Donadio A; Villani AR; Cagozzi L; Garavelli L; Bernasconi S
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():289-92. PubMed ID: 12729406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients.
    Hutter S; Piro RM; Waszak SM; Kehrer-Sawatzki H; Friedrich RE; Lassaletta A; Witt O; Korbel JO; Lichter P; Schuhmann MU; Pfister SM; Tabori U; Mautner VF; Jones DTW
    Hum Genet; 2016 May; 135(5):469-475. PubMed ID: 26969325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 1 and precocious puberty.
    Virdis R; Sigorini M; Laiolo A; Lorenzetti E; Street ME; Villani AR; Donadio A; Pisani F; Terzi C; Garavelli L
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():841-4. PubMed ID: 10969931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.
    Anastasaki C; Chatterjee J; Koleske JP; Gao Y; Bozeman SL; Kernan CM; Marco Y Marquez LI; Chen JK; Kelly CE; Blair CJ; Dietzen DJ; Kesterson RA; Gutmann DH
    Neuro Oncol; 2024 Aug; 26(8):1496-1508. PubMed ID: 38607967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromin in the brain.
    Gutmann DH
    J Child Neurol; 2002 Aug; 17(8):592-601; discussion 602-4, 646-51. PubMed ID: 12403558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
    Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
    Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological malignancies in neurofibromatosis type 1.
    Eoli M; Saletti V; Finocchiaro G
    Curr Opin Oncol; 2019 Nov; 31(6):554-561. PubMed ID: 31436563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.